Shades of purple filled Titiwangsa Lake this morning as more than 400 participants gathered for ‘Walk A Payung 2025’, a three ...

Shades of purple filled Titiwangsa Lake as more than 400 participants gathered for Walk A Payung 2025, a 3km walking ...

and cardiac symptoms and it was a relief to know what was the cause. As many lupus patients know, we don’t always look sick, and it can be challenging at times to navigate the healthcare system. I was ...

Merck Presents Positive Phase 2 Data for Enpatoran Demonstrating Reduction in Disease Activity in Patients with Cutaneous Lupus Erythematosus (CLE) and Systemic Lupus Erythematosus (SLE) with Active L ...

Q4 2024 Earnings Call Transcript May 29, 2025 Roivant Sciences Ltd. misses on earnings expectations. Reported EPS is $-0.22 ...

and cutaneous lupus erythematosus (CLE) being two primary forms. Symptoms can range from mild to life-threatening, often including fatigue, joint pain, rashes and organ involvement. Lupus ...

Cohort analyses from the WILLOW study reveal clear proof of concept in patients with CLE and SLE with active lupus rash, showing clinically meaningful ...

When skincare expert Leah Chavie was diagnosed with Raynaud’s disease, it didn’t mark the end of her journey — it became the beginning of a new one. Leah Chavie, founder and ...

Additional risk factors include contact lens wear, previous eye surgery, residence in dry climates, excessive screen time, ...

WILLOW is a global, multicenter, randomized, placebo-controlled Phase 2 study evaluating three doses of enpatoran taken twice daily (25 mg, 50 mg and 100 mg) versus placebo plus standard of care (SoC) ...

A Ghanaian and survivor of multiple sclerosis, Nathalie Busari, tells GRACE EDEMA how she regained her sight and the ability ...

Riya began to get "off" feelings at the age of 22. Her symptoms were subtle: body aches, periodic low-grade fevers, fatigue ...